NEJMÊÙ¶¯²ñ2003¡¡Âè4²ó03/02/12 ¼Â»Ü¡¡A¥×¥ê¥ó¥È¡¡Ã´Åö¡§Â¢Ìî¡¡¿® (kurano-tky@umin.ac.jp)
Case 31-2002:¡¡A 61-Year-Old Man with Headache and Multiple infarcts (Volume 347(15))
¨¡¨¡¨¡Æ¬ÄË¡¢Â¿È¯À­¹¼ºÉ¤¬Ç§¤á¤é¤ì¤¿61ºÐÃËÀ­¨¡¨¡¨¡

¡Ú´µ¼Ô¡Û 61ºÐÃËÀ­
¡Ú¼çÁÊ¡Û ÊÒËãáã¡¢¼º¸ì¡¢°Õ¼±ÆßËã
¡Ú¸½ÉÂÎò¡Û £±¥ö·îÁ°¤Þ¤Ç¤Ï¥Ï¥¤¥Á¤Î²È¤ÇÌäÂê¤Ê¤¯²á¤´¤·¤Æ¤¤¤¿¤¬¡¢±¦µÓ¤ËÄˤߤ¬À¸¤¸¤¿¡££²Æü¸å²¼»è¤ÎUS¤Ë¤è¤ë¸¡ºº¤ò¼õ¤±¤¿¤¬¡¢°Û¾ï¤Ïȯ¸«¤µ¤ì¤º¡¢¥¢¥¹¥Ô¥ê¥ó¤ò½èÊý¤µ¤ì¤¿¡£ÄˤߤϤʤ¯¤Ê¤Ã¤¿¤¬¡¢Æþ±¡£³½µ´ÖÁ°¤Ë¡¢Æ¬ÄË¡¢°­¿´¡¢Åǵ¤¤¬À¸¤¸¤¿¤¬¡¢¤³¤ì¤é¤Î¾É¾õ¤Ï¤·¤Ð¤é¤¯¤·¤Æ¤Ê¤¯¤Ê¤Ã¤¿¡££²Æü¸å¡¢Ê¿¹Õ´¶³Ð¤ËÌäÂ꤬À¸¤¸¤¿¡£´ÎUS¤Ç¼ðáç¤Îµ¿¤¤¡¢Êظ¡ºº¤ÇEntamoeba histolytica¡ÊÀÖΡ¥¢¥á¡¼¥Ð¡Ë¤¬¸«¤Ä¤«¤ê¡¢£±½µ´Ö¥á¥È¥í¥Ë¥À¥¾¡¼¥ë¤¬½èÊý¤µ¤ì¤¿¡£Æþ±¡£²½µ´ÖÁ°¡¢Ê¿¹Õ´¶³Ð¤ÎÌäÂê¤Ï¤Ê¤¯¤Ê¤ê¡¢CT¾åǾ¤Ë°Û¾ï¤Ï¸«¤¨¤Ê¤«¤Ã¤¿¡£Æþ±¡£±½µ´ÖÁ°¡¢Ê¢ÄË¡¢´Ö·çÀ­Æ¬Äˤ¬À¸¤¸¤¿¡£USA¤ËÅϹҤ¹¤ëºÝ¡¢Ì¾Á°¤ò½ñ¤¯¤Î¤Ëº¤Æñ¤¬¸«¤é¤ì¡¢Áý°­¤¹¤ë²ñÏäξ㳲¡¢ºÆȯ¤¹¤ëƬÄË¡¢±¦µÓ¤Î¿ê¼å¤¬¸«¤é¤ì¤¿¡£¿ê¼å¤Ï¤Þ¤â¤Ê¤¯¤·¤Æ±¦¾å»è¤Ë¤âÀ¸¤¸¡¢¼º¸ì¤È¤Ê¤Ã¤¿¡£³ÐÀä·¤¿¾õÂÖ¤Çɱ¡¤Ë±¿¤Ð¤ì¤¿¤¬¤¹¤°¤Ë°Õ¼±ÆßË㤬¸«¤é¤ì¤¿¡£µ¤´ÉÁ޴ɤ¬¹Ô¤ï¤ì¤¿¡£
¡ÚÀ¸³èÎò¡¦´û±ýÎò¡Û ¥Ï¥¤¥Á¤ÎÅļˤǰé¤Ã¤¿¡£µÊ±ì¤Ï£±£¸Ç¯Á°¤Ë¤ä¤á¤Æ¤ª¤ê¡¢¥¢¥ë¥³¡¼¥ë¤ÏŬÎÌ¡£Type2DM¤Î´û±ý¤¬¤¢¤ê¡¢·Ð¸ýÌô¡Ê¾ÜºÙÉÔÌÀ¡Ë¤òÉþÍѤ·¤Æ¤¤¤ë¡£²È²Îò¤ÏDM¤Î¿ÆÀ̤¬¿ô¿Í¤¤¤Æ¡¢Ëå¡Ê»Ð¡Ë¤¬»°²óÂè»°´ü¤Ë¼«Á³Î®»º¡Ê¸¶°ø¤ÏÄ´¤Ù¤Æ¤¤¤Ê¤¤¡Ë¡¢Ç¾Â´Ãæ¡¢¶Å¸Ç·Ï¼À´µ¤Î²È²Îò¤Ï¤Ê¤·¡£²È²¤ÎÏäˤè¤ë¤È¡¢´µ¼Ô¤Ï¶»ÄË¡¢¸ÆµÛº¤Æñ¡¢È¯Ç®¡¢´¨µ¤¡¢¿²´À¡¢ÂνŸº¾¯¡¢³ù¾õÀÖ·ìµå¾É¡¢Æ°Êª¡¦·ë³Ë¤Ø¤Î˽Ϫ¤Ï¤Ê¤¤¡£
¡ÚÆþ±¡»þ¸½¾É¡Û (°ìÈ̽긫)Âβ¹36.4¡î¡¢Ì®Çï137¡¢¸ÆµÛ¿ô20¡¢·ì°µ165/75mmHg¡£¿ÈÂθ¡ºº¤Ç¤Ï°Õ¼±ÆßËã¤Ç¡¢»É·ã¤ËÂФ·¤ÆºÇ¾®¤ÎÈ¿±þ¤·¤«¤·¤Ê¤¤¡£
(ÂÎɽ¡Ë¹ÈÈá¢ÅÀ¾õ½Ð·ì¡¢ÇÔ·ì¾É¡¢¥ê¥ó¥ÑÀá¼ðı¤Ï¸«¤é¤ì¤Ê¤¤¡£¶¯Ë첫áÕ¤¬Ç§¤á¤é¤ì¤¿¡£
(ÇÙ¡¦¿´)ÇÙ¤ÏÀ¶²»¡£Grade£²¤Î»¨²»¤¬apex¤Ë¸«¤é¤ì¤¿¡Ê­·¡Ý¡Ë¡£
(Ê¢Éô½ê¸«)´Î¡¤Ï¹Å¤¯±¦Ï¾¹üµÝ²¼4¡Á5cm¿¨¤ì¤¿¡£
(·ìή)·ì´É»¨²»¤ÏÄ°¤³¤¨¤Ê¤«¤Ã¤¿¤¬¡¢Ì®¤Ïº¸·ÛÆ°Ì®(¡Ý¡Ë¡¢±¦·ÛÆ°Ì®¡¢Î¾Â¦Üö¹üÆ°Ì®¡¢ÂçÂÜÆ°Ì®¡¢É¨ãÝÆ°Ì®(¡Ü¡Ü)¡£º¸²¼»è¤Ï¤Õ¤¯¤é¤Ï¤®¤è¤ê²¼¤ÏÁóÇò¤·¤Æ¤¤¤ÆÎ䤿¤¯¡¢º¸¸åæú¹üÆ°Ì®¤È­ÇØÆ°Ì®¤ÏÌ®¤¬¿¨¤ì¤Ê¤«¤Ã¤¿¡£°ìÊý±¦Â­¤Ï²¹¤«¤¯¡¢±¦¸åæú¹üÆ°Ì®¤È­ÇØÆ°Ì®¤ÎÌ®¤Ï¿¨¤ì¤Ê¤«¤Ã¤¿¤¬¡¢Doppler echo¤Ç·ìή¤Ï³Îǧ¡£¤µ¤ì¤¿¡£¤Þ¤¿Ëö¾¿Éâ¼ð¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£
(¿À·Ð³ØŪ½ê¸«¡Ë¶»¹ü¤Î°µÇ÷¤ËÂФ·¤Æº¸¾å»è¡¢º¸²¼»è¤ò¾¯¤·Æ°¤«¤¹È¿±þ¤ò¤¹¤ë¡£Æ·¹¦¤Ïľ·Â4mm¤ÇÂоΡ¢È¿±þÀ­¤¢¤ê¡£Gaze preference¤Ê¤·¡£±¦¾å»è¤ÏÃдˤ·¤Æ¤¤¤Æ¡¢¿¼Éôç§È¿¼Í¤Ïξ¦¤È¤â¤Ë¤¢¤ë¡£¥Ð¥Ó¥ó¥¹¥­¡¼È¿±þ¤Ï¸«¤é¤ì¤Ê¤¤¡£
(Ç¢)¿§¤Ï¥ª¥ì¥ó¥¸¡£ÃÁÇò(++)¡¢¥Ó¥ê¥ë¥Ó¥ó(+)¡¢¥¦¥í¥Ó¥ê¥Î¡¼¥²¥ó(¡Þ)¡¢RBC3~5/HPF¡¢WBC2/HPF¡¢ºÙ¶Ý¾¯¿ô/HPF¡£
(·ì±Õ¸¡ºº¡¢À¸²½³Ø¸¡ºº)¢ªTable1,2¡£Ca, amylase, creatine kinase¤ÏÀµ¾ï¡£
(·ì±Õ¥¬¥¹¸¡ºº)PaO2 189mmHg PaCO2 37mmHg pH 7.33¡Ê»ÀÁÇÊä½¼²¼¡Ë
(¿´ÅÅ¿Þ)¿´Çï¿ô140¤ÎƶÀ­ÉÑÌ®¤Ç»þ¡¹Ááȯ¤ÎQRS complex¤òȼ¤¦¡£²¼Êɤª¤½¤é¤¯³°Â¦¤Î(acute?)
MI¤Î¥Ñ¥¿¡¼¥ó¤Ç¤¢¤Ã¤¿¡£
(CXR)µ¤´É¥Á¥å¡¼¥Ö¤ÏŬÀڤʰÌÃÖ¤ËÆþ¤Ã¤Æ¤¤¤¿¡£º¸ÇÙÄì¤ËÈþõ̵µ¤ÇÙ¤¬¸«¤¨¤ë¡£Â¾¤ÎÉôʬ¤ÎÇÙ±¢±Æ¡¢¿´±¢±Æ¤ÏÀµ¾ï¤¢¤Ã¤¿¡£
(CT&MRI of the brain)¿ȯÀ­¹¼ºÉ¡¡¢ªfig1,2¡¡¡¡¡¡¡¡¡¡(CT of the abdomen) ¢ªfig3,4,5
 
¡ÚÆþ±¡¸å·Ð²á¡Û ´µ¼Ô¤ÏICU¤ËÆþ±¡¤·¤¿¡£Ç¢É¸ËÜ¡¢·ì±ÕɸËܤòºÎ¼è¤·ÇÝÍܤ·¤¿¡£single dose ceftriaxone¤Èvancomycin¤¬½èÊý¤µ¤ì¤¿¡£¼£ÎŤÏ¾¤Ë¥¢¥¹¥Ô¥ê¥ó(325mg/day)¡¢¾¯Î̥إѥê¥ó¡¢Ä̾磻¥ó¥¹¥ê¥ó¡¢¥á¥È¥í¥×¥í¥í¡¼¥ë¤òÅêÍ¿¤·¤¿¡£·Ð¿©Æ»¥¨¥³¡¼¤¬¹Ô¤ï¤ì¤¿¡£¡Ê¢ªfig6¡Ë Æþ±¡2ÆüÌÜ¡¢Âβ¹¤Ï37.7¡î¤òĶ¤¨¤Ê¤«¤Ã¤¿¡£¸¡ººÃͤϾ¯¤·ÊѤï¤Ã¤¿¡£(¢ªtable2)¡¡HBs-Ab(+), HBs-Ag(-), HCV-Ab(-), HIV-1-Ab(-), HIV-2-Ab(-), RF(-) .CXR¤Ç¤Ïξ¦ÇÙÄìÉô¤Î̵µ¤ÇÙ¡¢º¸ÇÙÃæÉô¤Î̵µ¤Ç٤ε¿¤¤¡£¿Õ¥ì¥ó¥È¥²¥ó¸¡ºº¤Ç¤Ï¡¢º¸¿Õ¡§²¼¶Ë¤Î¾®Îΰè(ÃÙ±äÁêÍ¥°Ì¤Îtracer¤Î¼è¤ê¹þ¤ß)¤ò½ü¤­Â¤±ÆºÞ¤Î¼è¤ê¹þ¤ß̵¤·¡¢±¦¿Õ¡§Àµ¾ï¤Î¤±Æ¤ò¼¨¤¹¤¬¡¢ÇӽФÏÃÙ¤ì¤Æ¤¤¤ë¡£CT study of the brain¡§Á°Æü¤ÈÊѲ½¤Ê¤·¡¡ Á°Æü¤ÎÇÝÍÜ·ë²Ì¡§¤¹¤Ù¤Æ±¢À­
 
¤¢¤ë¿ÇÃÇŪ¼êµ»¤¬»Ü¹Ô¤µ¤ì¤¿¡¥
 
 




 
  ¡Ú²èÁü½ê¸«¡Û
(Dr. Pamela W. Shaefer)¡¡fig-1¤ÎCT¤Ë¤Ä¤¤¤Æ¡£º¸Á°Æ¬ÍÕ¡¢º¸Æ¬ÄºÍÕ¤Ëlow density area¡¢³¥Çò¼Á¤ÈÇò¼Á¤Î¶­³¦¾Ã¼º¡¢local mass effect¡£º¸ÃæÂçǾư̮¤ÎÎΰè¤ÎµÞÀ­¹¼ºÉ¤ò¼¨¤¹¡£¤Þ¤¿¡¢Î¾Â¦À­¤Î¾®Ç¾¹¼ºÉ¤âǧ¤á¤ë¡£
fig-2¤ÎMRI¤Ë¤Ä¤¤¤Æ¡£¤¤¤¯¤Ä¤«¤Î·ì´ÉÎΰè¤Ë¿ȯÀ­µÞÀ­¹¼ºÉÁü¤ò¼¨¤¹¡£¡ÊºÇÂç¤Î¹¼ºÉ¤Ïº¸ÃæÂçǾư̮¤Ë¸«¤¨¡ÒÁ°Æ¬ÍÕ¸åÉô¡¢Æ¬ÄºÍÕ¡¢Â¦Æ¬ÊÛ³¸Éô¤Ë¹­¤¬¤ë¡Ó¡¢Â¾¤Ë¤â¾®¤µ¤Ê¹¼ºÉ°è¤¬º¸±¦ÂçǾư̮¡¢¾®Ç¾¤Ê¤É¤Ë¸«¤¨¤ë¡£¡Ë°¡µÞÀ­¹¼ºÉ°è¤¬±¦¾å¡¢¸å²¼¾®Ç¾Æ°Ì®¤Ë¸«¤é¤ì¤ë¡£MRA¤Ç¤ÏWillisÆ°Ì®Îؤ˰۾ï¤Ï̵¤¤¡£
(Dr. Brian C. Lucy)¡¡Ê¢ÉôCT¤Ë¤Ä¤¤¤Æ¡£Î¾Â¦ÇÙÄìÉô¤Î̵µ¤ÇÙ¡¢ÇÙ¤Îmasses¤Þ¤¿¤Ïnodules¡¢¶»¹ÐÆâ¥ê¥ó¥ÑÀá¼ðı¡¢ÂçÆ°Ì®¡¦Ä²´ÖËìÆ°Ì®¤Î°Û¾ï¤¬¤¢¤ë¡£´Î(fig-3)¤Ë¤ÏξÍդ˿ȯÀ­Áã¾õÎΰè¡Êlow density 2~20mm¡¢Â¤±Æ¤ÇÌçÌ®Áê¤Ë¥â¥¶¥¤¥¯¾õ¤±Æ¡£±¦Íդ˿¤¯¡¢Í»¹ç¤·¤Æ¤¤¤ë¤è¤¦¤Ë¸«¤¨¤ë¡Ë¤¬¤¢¤ê¡¢¼Â¼Á¤Ë¤Ï¹¼ºÉ¤òµ¿¤ï¤»¤ë½ê¸«¤¬¤¢¤ë¡Êlow enhancement¤ÎÎΰè¡Ë¡£ÃÀ´É¤Î³ÈÄ¥¤Ï̵¤¯¡¢´§Æ°Ì®¡¢ÌçÌ®¤Ï´ÓÄ̤·¤Æ¤¤¤ë¡£¿Õ(fig-4)¤Ïξ¿Õ¤Ë¹¼ºÉÁü¤Ë°ìÃפ¹¤ëÄ㤱ÆÁü¤¬¸«¤¨¤ë¤¬º¸¿Õ¤Î¤Û¤¦¤¬¹¼ºÉ¤¬¶¯¤¤¤È¹Í¤¨¤é¤ì¤ë¡£ÌÕIJ¤È¾å¹Ô·ëIJ(fig-5)¤ÎÊɤϸü¤¯¡¢³ÈÄ¥¤Ê¤É¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£²èÁü½ê¸«¤È¤·¤Æ¤ÏÈóÆðÛŪ¤Ç¤¢¤ë¤¬¡¢·ëIJ±ê¤Î½ê¸«¤Ç¤¢¤ë¡£¾å¹Ô·ëIJ¤Î¼þ¤ê¤Î»éËᢴα¦ÍÕ²¼Ì̤ËÈóÆðÛŪ¤Ê±ê¾ÉÀ­ÊѲ½¤¬¸«¤¨¤ë¡£¤³¤Î½ê¸«¤Ïfocal ischemic colitis¤ò¼¨º¶¤·¤Æ¤¤¤ë¡£
(Dr. Mary Etta King)¡¡·Ð¶»ÊÉ¿´¥¨¥³¡¼¤Ë¤Ä¤¤¤Æ¡£MI¤Î´û±ý¤«¤é»Ü¹Ô¤·¤¿¡£Ä¹¼´Êý¸þ¤Ç¤Ï¡¢ÁÎ˹ÊÛÁ°Àí¤¬¤ÓËýÀ­¤ËÈî¸ü¤·¤Æ¤¤¤¿¡£ÁÎ˹ÊÛ¤ÏÆýƬ¶Ú¤Îµ¡Ç½ÉÔÁ´¤¬¤¢¤ê¡¢ÉÔ´°Á´Àܹç¤ò¼¨¤·¤¿¡£MR¤¬¸«¤é¤ì¤¿¡£ÂçÆ°Ì®ÊۤϤ鷺¤«¤ËÈî¸ü¤·¤Æ¤¤¤¿¤¬¡¢ÌÀ¤é¤«¤Êvegetation¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£Ã»¼´Êý¸þ¤Ç¤Ïº¸¿´¼¼ÍÆÎÌ¡¢¼ý½Ì´üµ¡Ç½¤ÏÀµ¾ï¡£Apical view¤Ç¤Ïapex¤ÎʬÀáÀ­µ¡Ç½ÉÔÁ´¡¢ÁÎ˹ÊۤΤÓËýÀ­Èî¸ü¡¢mild MR¤¬Doppler echo¤Ç¸«¤Ä¤«¤Ã¤¿¡£·×»»¤µ¤ì¤¿º¸¿´¼¼ejection fraction¤Ï£µ£²%¤Ç¤¢¤ê¡¢·ÚÅÙ¿´ÉÔÁ´¤¬¤¢¤ë¡£¿©±ö¿å¤¬·ÐÀÅ̮Ū¤ËÅêÍ¿¤µ¤ì¤¿¤¬¡¢°ÂÀÅ»þ¡¢¥Ð¥ë¥µ¥ë¥Ð¥Æ¥¹¥È»þ¤È¤â¤Ë¡¢±¦¿´Ë¼¡¢±¦¿´¼¼¤Ë¤ÏÇ»¤¤º®Âù²½¤¬¸«¤é¤ì¤¿¤¬º¸¿´Ë¼¡¢º¸¿´¼¼¤Ë¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£Â¤±Æ¤Ç¤Ï¿´Â¡Æⱦº¸¥·¥ã¥ó¥È¤Ï¸«¤é¤ì¤Ê¤«¤Ã¤¿¡£
 
 

fig-1


fig-2


fig-3


fig-4


fig-5